KRAS and pancreatic neoplasm: Since mutations in K-Ras are nearly universal in PDAC and the activity level of Ras appears to be a key mechanism controlling the development of PDAC, we sought to determine whether Gal-3 affects Ras activity contributing to the pathogenesis of pancreatic cancer.